BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16775424)

  • 1. Identification of the genes for kidney cancer.
    Linehan WM
    Cancer Biol Ther; 2006 Jun; 5(6):696-9. PubMed ID: 16775424
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited renal cell carcinoma.
    Maher ER
    Br J Urol; 1996 Oct; 78(4):542-5. PubMed ID: 8944511
    [No Abstract]   [Full Text] [Related]  

  • 3. von Hippel-Lindau gene mutations in human and rodent renal tumors--association with clear cell phenotype.
    Gnarra JR
    J Natl Cancer Inst; 1998 Nov; 90(22):1685-7. PubMed ID: 9827515
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial non-VHL non-papillary clear-cell renal cancer.
    Teh BT; Giraud S; Sari NF; Hii SI; Bergerat JP; Larsson C; Limacher JM; Nicol D
    Lancet; 1997 Mar; 349(9055):848-9. PubMed ID: 9121264
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type.
    Meyer AJ; Hernandez A; Florl AR; Enczmann J; Gerharz CD; Schulz WA; Wernet P; Ackermann R
    Int J Cancer; 2000 Sep; 87(5):650-3. PubMed ID: 10925357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
    Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
    Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
    [No Abstract]   [Full Text] [Related]  

  • 10. VHL gene mutation and clear-cell renal carcinomas.
    Knudson AG
    Cancer J Sci Am; 1995; 1(3):180-1. PubMed ID: 9166471
    [No Abstract]   [Full Text] [Related]  

  • 11. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.
    Shah DR; Hoeksema J; Korbet SM
    Clin Nephrol; 2000 Mar; 53(3):216-21. PubMed ID: 10749302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
    Linehan WM; Lerman MI; Zbar B
    JAMA; 1995 Feb; 273(7):564-70. PubMed ID: 7837390
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
    Neumann HP; Bender BU; Berger DP; Laubenberger J; Schultze-Seemann W; Wetterauer U; Ferstl FJ; Herbst EW; Schwarzkopf G; Hes FJ; Lips CJ; Lamiell JM; Masek O; Riegler P; Mueller B; Glavac D; Brauch H
    J Urol; 1998 Oct; 160(4):1248-54. PubMed ID: 9751329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Hippel-Lindau syndrome with unusual presentations in two brothers.
    Saranga R; Matzkin H; Papo J; Braf Z
    Urology; 1989 Nov; 34(5):301-4. PubMed ID: 2815455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A family of von Hippel-Lindau disease with renal cell carcinoma--case report and review of the literature].
    Ito F; Uda M; Toma H
    Hinyokika Kiyo; 1991 Feb; 37(2):157-62. PubMed ID: 2048495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of familial renal cell carcinoma syndromes.
    Cohen D; Zhou M
    Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
    Sufan RI; Jewett MA; Ohh M
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease.
    King CR; Schimke RN; Arthur T; Davoren B; Collins D
    Cancer Genet Cytogenet; 1987 Aug; 27(2):345-8. PubMed ID: 3594418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of cancer of the kidney.
    Sudarshan S; Linehan WM
    Semin Oncol; 2006 Oct; 33(5):544-51. PubMed ID: 17045083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.